2015
DOI: 10.1007/s10571-015-0268-5
|View full text |Cite
|
Sign up to set email alerts
|

Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes

Abstract: The excitatory amino acid transporters 1 and 2 (EAAT1 and EAAT2), mostly located on astrocytes, are the main mediators for glutamate clearance in humans. Malfunctions of these transporters may lead to excessive glutamate accumulation and subsequent excitotoxicity to neurons, which has been implicated in many kinds of neurodegenerative disorders including Alzheimer’s disease (AD). Yet, the specific mechanism of the glutamate system dysregulation remains vague. To explore whether the insulin/protein kinase B (Ak… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 23 publications
(32 citation statements)
references
References 54 publications
3
28
1
Order By: Relevance
“…Furthermore, regulation of prion diseases pathway by miR-27a, miR-146a, and miR-155, reinforces the hypothesis that AMD can be a protein misfolding disease, such as AD, due to deposition of Aβ oligomers in drusen bodies. The potential link between AMD and AD is also in line with the deregulation of insulin receptor signaling by miR-27a, miR-146a, and miR-155 (Giuffrida et al, 2012; Gontier et al, 2015; Takach et al, 2015; Han et al, 2016; Sajan et al, 2016; Table 4A). The set of miRNAs differentially expressed in AMD patients can regulate the same pathways of miRNAs dysregulated in the animal model of AMD (Figure 4 and Table 4B).…”
Section: Resultsmentioning
confidence: 75%
“…Furthermore, regulation of prion diseases pathway by miR-27a, miR-146a, and miR-155, reinforces the hypothesis that AMD can be a protein misfolding disease, such as AD, due to deposition of Aβ oligomers in drusen bodies. The potential link between AMD and AD is also in line with the deregulation of insulin receptor signaling by miR-27a, miR-146a, and miR-155 (Giuffrida et al, 2012; Gontier et al, 2015; Takach et al, 2015; Han et al, 2016; Sajan et al, 2016; Table 4A). The set of miRNAs differentially expressed in AMD patients can regulate the same pathways of miRNAs dysregulated in the animal model of AMD (Figure 4 and Table 4B).…”
Section: Resultsmentioning
confidence: 75%
“…Once cells were differentiated, all subsequent treatments and experiments were carried out in DMEM without FBS. The dose of Ab (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35) and treatment times were chosen considering glial fibrillary acidic protein levels as the indicator of reactive astrocytes (data not shown). Likewise, we used HT concentration that should be of physiological relevance [32] and that did not induce cytotoxicity [41].…”
Section: Cell Differentiation and Treatment Of Astrocytesmentioning
confidence: 99%
“…All membranes were incubated with the primary antibodies (diluted 1:1000) in blocking buffer at 48C overnight. The membranes were washed three times with TTBS and incubated with the corresponding secondary antibody Experimental groups originating from different treatment combinations with hydroxytyrosol (HT) 5 mM for 2 h (pre-treatment) and/or 24 h (posttreatment), and treatment for 24 h with amyloid b peptide (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35) BioFactors conjugated with horseradish peroxidase (Thermo Fisher Scientific, Inc., Waltham, MA) at a dilution of 1:2,000 or 1:5,000 depending on primary antibody, in nonfat milk during 90 min at 258C. All proteins were detected by chemiluminescence using an ECL system (PerkinElmer Life Sciences, Boston, MA) and quantified by densitometry using Adobe Photoshop's (Adobe systems, Inc., Mountain View, CA).…”
Section: Western Blottingmentioning
confidence: 99%
See 2 more Smart Citations